Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-15,695
Closed -$1.19M 4187
2026
Q1
$1.19M Buy
15,695
+1,189
+8% +$89.4K 0.06% 299
2025
Q4
$1.08M Buy
14,506
+4,681
+48% +$342K 0.05% 296
2025
Q3
$663K Buy
9,825
+2,556
+35% +$170K 0.04% 420
2025
Q2
$474K Buy
7,269
+4,100
+129% +$246K 0.03% 507
2025
Q1
$196K Sell
3,169
-1,117
-26% -$74K 0.01% 776
2024
Q4
$309K Buy
4,286
+454
+12% +$35.5K 0.03% 530
2024
Q3
$312K Buy
3,832
+582
+18% +$46.6K 0.03% 455
2024
Q2
$241K Buy
3,250
+757
+30% +$56.7K 0.03% 453
2024
Q1
$194K Buy
2,493
+408
+20% +$30.4K 0.04% 398
2023
Q4
$155K Buy
+2,085
New +$145K 0.04% 386

Other funds holding HOLX

GAMMA Investing's HOLX Position: Q2 2026 in Review

GAMMA Investing sold out of Hologic (HOLX) in Q2 2026, closing a stake of 15,695 shares — an estimated $1.19M sold.

GAMMA Investing first reported a position in HOLX in Q4 2023 and held it in 10 quarters. The position peaked at $1.19M in Q1 2026. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • GAMMA Investing reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • GAMMA Investing sold 15,695 Hologic shares in Q2 2026, an estimated $1.19M.
  • GAMMA Investing first reported a position in Hologic in Q4 2023 and held it in 10 quarters.
  • GAMMA Investing's Hologic position peaked at $1.19M in Q1 2026.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.